Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Find the answer quickly by clicking your desired question.
Q- How specific is TAL? Off-site targeting?
Q- Are TAL-meditated KO or KI strains considered to be GMO?
Q- How big is TAL? Or what’s the size of TALs?
Q- Can TALs be delivered by retroviruses?
Q- Can TALs recognize degenerate binding sites?
Q- Can or how Life Technologies guarantee that TALs will work in the first place?
Q- How fast can I get TALs made so that I can do my KO or KI experiments?
Q- What is the best delivery vehicle for TALs, transfection, electroporation or retroviruses?
A- Recent paper by Prashant Mali in Nature Biotechnology shows that TALs are tolerant to 1-2 mismatches and less to large majority of 3 bp mismatches.
A- KO and KI involves editing the native genetic code by either mutating or deleting a encoded message or inserting a new piece of information at a desired site. Although this does manipulate the native genetic information, this technology when used in a responsible manner has very useful applications like engineering yeasts for insulin production or engineering cells for more economically and clinically valuable products.
A- 3.3 Kb TALDNA
A- If viral based delivery is the option then Adenoviral systems are better than lento.
A- By careful designing they can be engineered to be very specific. Note: recent publications show that 1-3 base pair mismatch in target DNA sequence can be tolerated to a large extent.
A-Careful design followed by in vitro validation as well as cleavage analysis to validate the designed TALs.
A- Manufacturing typically 2 weeks after order has been placed.
A- mRNA or DNA with lipid for standard test cell lines ex., 293 hela ets, mRNA delivery also circumvents the threat of transgene integration. Where as for for stem cell electroporation is comparatively a better option.